Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612685 · ClinicalTrials.gov registry record · NA
Healthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families
A NA study of Depression and Stress, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT05612685: Completed NA study of Depression and Stress, sponsored by University of California, Los Angeles.
NCT05612685 is a NA study of Depression and Stress that has completed, run by University of California, Los Angeles. The registered enrollment target is 21 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612685, a NA study of Depression and Stress, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot test the feasibility and preliminary efficacy of healthcare provider referrals to a tax filing app within parent-child health programs to test whether such referrals can increase receipt of tax credits among low-income parents. The study will use a single-group, pre/post test design with a sample of parents who have a child under 6 years of age. Participants will be recruited from parental-child health programs and clinics in Los Angeles and will complete surveys at baseline, immediately after tax filing season, and six months after tax filing season to assess 1) frequency of tax filing after referral (Feasibility), and 2) pre/posttest changes to parent and child health (preliminary efficacy).
Primary Outcome
Self-reported tax filing status for the current year
Conditions Studied
Interventions
- BEHAVIORAL Healthcare provider referral to a tax filing app
Study Locations (1)
California
- UCLA School of Nursing - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT05612685 record still lists
NCT05612685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Healthcare provider referral to a tax filing app is the first listed.
NCT05612685 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05612685 about?
NCT05612685 is a clinical study titled "Healthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families". The purpose of this study is to pilot test the feasibility and preliminary efficacy of healthcare provider referrals to a tax filing app within parent-child health programs to test whether such referrals can increase receipt of tax credits among low-income parents. The study will use a single-group,...
What is the current status of trial NCT05612685?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-01-01. Estimated completion is 2025-05-31.
What conditions does trial NCT05612685 study?
This clinical trial studies the following conditions: Depression, Stress, Child Development, Health Care Utilization, Physical Illness.
What interventions are being tested in trial NCT05612685?
The interventions under investigation include: Healthcare provider referral to a tax filing app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05612685?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05612685 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05612685's enrollment target sits among peer trials
21 607th of 679 higher than 69 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy